A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MI / myometrial invasion

[Related PubMed/MEDLINE]
Total Number of Papers: 65
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MI  (>> Co-occurring Abbreviation)
Long Form:   myometrial invasion
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Adjuvant chemotherapy in endometrial cancer. CT, EBRT, EC, LVSI, VBT
2020 Validation of ultrasound strategies to assess tumor extension and to predict high-risk endometrial cancer in women from the prospective IETA (International Endometrial Tumor Analysis)-4 cohort. AP, AUC, CSI, IETA, SA
2019 A novel prediction method for lymph node involvement in endometrial cancer: machine learning. CGSI, EC, LNI, LVSI, PaLNI
2019 Accuracy of frozen section at early clinical stage of endometrioid endometrial cancer: a retrospective analysis in Germany. EC, FS
2019 Association between Morphological Patterns of Myometrial Invasion and Cancer Stem Cell Markers in Endometrial Endometrioid Carcinoma. AM, CD, CSC, EEC, FIGO, LN, MELF, PR
2019 Can dynamic contrast-enhanced ultrasound (DCE-US) improve diagnostic performance in endometrial cancer staging? A proof of concept. CSI, DCE-US, EC, IETA
2019 Clinical and Ultrasound Characteristics of the Microcystic Elongated and Fragmented (MELF) Pattern in Endometrial Cancer According to the International Endometrial Tumor Analysis (IETA) criteria. IETA, MELF
2019 FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-beta1 and NF-kappaB Pathways. EC, mRNA, NF, PAI, siRNA, TGF, TNF, UA
2019 Magnetic Resonance Imaging (MRI) and Three-Dimensional Transvaginal Ultrasonography Scanning for Preoperative Assessment of High Risk in Women with Endometrial Cancer. CI, LNM, MRI
10  2019 Prognostic role of PET/CT in endometrial cancer. CI, CT, DM, EC, FDG, LNM, LVI, MTV, OS, PET, PFS, TLG
11  2019 Prognostic value of metabolic tumor volume and total lesion glycolysis from ⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma. EC, LNMs, MTV, TLG
12  2019 Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study. CCC, CI, HR, LVSI, UPSC
13  2018 Clinicopathological and prognostic significance of blood microvessel density in endometrial cancer: a meta-analysis and subgroup analysis. BMVD, LNM, LVSI, OS, SMD
14  2018 Endometrial cancer off-line staging using two-dimensional transvaginal ultrasound and three-dimensional volume contrast imaging: Intermethod agreement, interrater reliability and diagnostic accuracy. CSI
15  2018 Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors in endometrial cancer. LVSI, TFD
16  2018 Preoperative Magnetic Resonance Volumetry in Predicting Myometrial Invasion, Lymphovascular Space Invasion, and Tumor Grade: Is It Valuable in International Federation of Gynecology and Obstetrics Stage I Endometrial Cancer? MR, TVR
17  2018 The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes. DFS, FIGO, LRFS, LVI, OS, SO
18  2017 Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in a Multi-institutional Cohort of 165 Cases. CCC, DFI, OS
19  2017 Correlation of Minimum Apparent Diffusion Coefficient and Maximum Standardized Uptake Value of the Primary Tumor with Clinicopathologic Characteristics in Endometrial Cancer. DW-MRI, EC, FDG, LVSI, NPV, PET/CT
20  2017 Para-aortic lymphadenectomy can be omitted in most endometrial cancer patients at risk of lymph node metastasis. EC, PALN, PLN
21  2017 Preoperative Serum Human Epididymis Protein 4 Levels in Early Stage Endometrial Cancer: A Prospective Study. HE4
22  2017 Reproducibility of measurement of myometrial invasion in endometrial carcinoma. DOI, TFD
23  2017 Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study-On behalf of the Swedish Gynecological Cancer Group. CI, LNM, RR
24  2016 Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus. CT, HIPAA, NPV, PPV
25  2016 Optimal cytoreduction, depth of myometrial invasion, and age are independent prognostic factors for survival in women with uterine papillary serous and clear cell carcinomas. OR, OR, OS, PFS, UCCC, UPSC
26  2016 To what extent is risk grouping method successful in deciding surgical staging in endometrial cancer? CSS, EC, HR, LND, LNM, LR, TS
27  2016 Tumor diameter as a predictor of lymphatic dissemination in endometrioid endometrial cancer. LD, TD, TD50
28  2015 Detection of circulating tumor cells in high-risk endometrial cancer. CTCs, EC
29  2015 Intraoperative Ex Vivo High-Resolution Sonography: A Novel Technique for the Assessment of Myometrial Invasion in Endometrial Cancer. EC, FS, IEVHS
30  2015 Preoperative MRI and intraoperative frozen section diagnosis of myometrial invasion in patients with endometrial cancer. FSs, MRI, PSs
31  2015 Prognostic significance of reduced immunohistochemical expression of E-cadherin in endometrial cancer-results of a meta-analysis. FIGO, HR, LNM, OR, OS
32  2015 The association of the microcystic, elongated and fragmented (MELF) invasion pattern in endometrial carcinomas with deep myometrial invasion, lymphovascular space invasion and lymph node metastasis. EA, LN, LVSI, MELF
33  2015 The evaluation of reliability and contribution of frozen section pathology to staging endometrioid adenocarcinomas. FS, LVSI, PS
34  2015 The impact of a vaginal brachytherapy boost to pelvic radiation in stage III endometrial cancer. CSI, LVSI, VBB
35  2014 Is the two-tier ovarian serous carcinoma grading system potentially useful in stratifying uterine serous carcinoma? A large multi-institutional analysis. HGUSC, HPF, LGUSC, LN, LVI, USC
36  2014 Maspin expression in endometrial hyperplasia and carcinoma, and its relation with angiogenesis. IHC, LVSI, OS, VEGF
37  2014 Risk stratification and prognosis determination using (18)F-FDG PET imaging in endometrial cancer patients: a systematic review and meta-analysis. CI, LVI
38  2014 The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline. ---
39  2013 Accuracy of frozen-section examination for myometrial invasion and grade in endometrial cancer. FS
40  2013 Preoperative and intraoperative assessment of myometrial invasion in endometrial cancer: comparison of magnetic resonance imaging and frozen sections. MRI
41  2013 Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma. DFS, GOG99, LVSI, OS, PR
42  2013 SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients. CI, LNM
43  2013 The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma. ED, LN, LUS, LVI, MELF, SCI
44  2012 A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. EC, IFSs, PSs
45  2012 Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer. EC, PTD
46  2012 Mucinous histology is a risk factor for nodal metastases in endometrial cancer. MUC
47  2012 Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer. DOI, NGOC, ROC, TFD
48  2010 Expression of ER, PR, and Her-2/neu in endometrial cancer: a clinicopathological study. EMC, ER, PR
49  2010 Intraoperative evaluation of myometrial invasion and histological type and grade in endometrial cancer: diagnostic value of frozen section. HTG
50  2010 Prognostic factors in stages II/III/IV and stages III/IV endometrioid and serous adenocarcinoma of the endometrium. DFS, DOD, EAC, LVI, OS
51  2009 Liquid-based preparation for endometrial cytology--usefulness for predicting the prognosis of endometrial carcinoma preoperatively. ERalpha, LBC, LVSI, PRB
52  2009 Preoperative and intraoperative assessments of depth of myometrial invasion in endometrial cancer. MRI
53  2009 Prognostic significance of several histological features in intermediate and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy. EBRT, FFS, LVSI, OS
54  2009 Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. CI, LI, SI
55  2008 Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. IMA, PTD
56  2007 Cost-effectiveness analysis of treatment strategies for Stage I and II endometrial cancer. HBSO, ICER, QALY, RT
57  2004 [Role of three-dimensional transvaginal sonography in evaluation of the depth of myometrial invasion of endometrial carcinoma]. ---
58  2002 Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma. EC, VSI
59  2002 Surgical stage I endometrial cancer: predictors of distant failure and death. DRS, RFS, RR
60  2001 High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. LAVH, TAH
61  2001 Outcome and management of pathological stage I endometrial carcinoma patients with involvement of the lower uterine segment. LUS, LVI
62  2000 Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. ---
63  2000 Do conventional pathologic features lose their prognostic significance following postoperative radiation therapy in pathologic stage I-II endometrial adenocarcinoma? LVI, RT
64  1999 Surgery and postoperative radiation therapy in stage II endometrial carcinoma. RT, VB, WPRT
65  1997 Risk factors predictive of para-aortic lymph node metastasis in endometrial carcinomas. CI, GST-pi, PAN, PLN, VSI